This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Aug. 21, 2013


 



MRI for breast cancer raises odds of surgery
Futurity
For older women with breast cancer, heavy use of magnetic resonance imaging may lead to unnecessary breast removal surgeries. "These data are concerning because the long-term benefits associated with bilateral mastectomy for older women with breast cancer are unclear," says the study's lead author.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  


Advertisement
SPONSORED CONTENT


Researchers discover potential new drug target in dividing cells
Cancer Research UK
U.K. researchers studying how cells divide have discovered a potential new target for cancer drugs. Their study published in the Journal of Cell Biology looks at the role played by a particular group of proteins in dividing cells. When it divides in two, a cell separates the DNA chromosomes in its nucleus into two identical sets to form the two new nuclei of the resulting cells.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Nanoparticles reprogram immune cells to fight cancer
Science World Report
Researchers at the University of Georgia are developing a new treatment technique that uses nanoparticles to reprogram immune cells so they are able to recognize and attack cancer. The human body operates under a constant state of martial law. Chief among the enforcers charged with maintaining order is the immune system, a complex network that seeks out and destroys the hordes of invading bacteria and viruses that threaten the organic society as it goes about its work.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Are you an Average or Above Average Doctor?

See how you match up against your peers in several financial categories with the MediGain Benchmark report. How does your compensation compare with other physicians in your specialty? What about your Charges and Reimbursements? Let us provide you with the insights into your practice that will mean more CASH for you.
 


What's my real cancer risk? When online calculators don't compute
NPR
Online risk calculators are all the rage these days among public health groups trying to get us to change our unhealthful ways. The World Health Organization developed an online tool that lets you estimate your personal risk of cracking a hip in the next 10 years, for example. Simply just plug in data about yourself, your lifestyle and your family medical history. Another calculator, sponsored by the Harvard School of Public Health, uses that sort of tailored data to help you compute your risk of having a stroke or of developing any of 12 kinds of cancer.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


New clues to origins of myeloma
Cancer Research UK
A gene that helps control ageing could also be linked to a type of blood cancer, according to an international team of researchers. The team, led by researchers at The Institute of Cancer Research in London, found that four specific areas of human genetic code — our genome — are linked to an altered risk of developing myeloma, a type of cancer comes from blood cells in the bone marrow.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


  FEATURED COMPANIES
Oncology OnTrack Supports Nurse Navigation
Oncology OnTrack is used to navigate patients with any cancer type from screening to diagnosis, treatment and survivorship, interfaces with other programs and supports accreditations.
Advertise here!

To find out how to feature your company in The CoC Brief and other advertising opportunities, contact James DeBois at 469-420-2618.
MORE


NICE approves new test for spread of breast cancer
Nursing Times
The test in question is called RD-100i OSNA, and is used during surgery to remove invasive breast cancer. This new test can tell doctors whether the cancer has spread to the lymph nodes by detecting abnormal genetic markers in samples taken from the lymph nodes. It does this by detecting abnormal genetic markers in samples taken from the lymph nodes. The test is expected to provide much faster results than conventional biopsies.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
Looking for similar articles? Search here, keyword BREAST CANCER.


Study links aging gene to blood cancer
Bioscience Technology
A gene that helps control the aging process by acting as a cell's internal clock has been linked to cancer by a major new study. Scientists at The Institute of Cancer Research, London, found a genetic variant that influences the aging process among four new variants they linked to myeloma — one of the most common types of blood cancer.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Longer funding cycles vital in cancer research
Health Canal
If we want to cure cancer we need to think like venture capitalists. We need to recognize that making a real impact in medical research demands big, radical ideas and the willingness to take commensurate risks.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Enobosarm, GTx lung cancer drug, fails in late-stage trials to test muscle-wasting prevention, treatment
Medical Daily
Recently, GTx Inc., a biopharmaceutical company based in Memphis, Tenn., announced that enobosarm, an experimental drug for lung cancer patients, failed in two Phase III clinical trials designed to test its ability to prevent and treat muscle wasting.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Total cancer death rate drops but progress slow on 'forgotten cancers'
The Conversation via Medical Xpress
Australia's mortality rate for all cancers has dropped 28 percent in 20 years, new figures show, but progress has been slow in the fight against thyroid and pancreatic cancer, while the death rate from liver cancer has skyrocketed.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Scientists take fight against prostate cancer from lab to clinic
UCLA
The awarding of $11.6 million in federal funding from the National Cancer Institute to enable a multidisciplinary group of UCLA scientists to continue their important prostate cancer research is just the latest in a string of "big hits" for the team.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Cigna moves to restrict cancer tests
Trib Live
Cigna Corp. will become the first health insurer to require genetic counseling nationwide before it pays for tests for hereditary breast and ovarian cancer, a move that may threaten sales for Myriad Genetics Inc.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
 




The CoC Brief

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Andrew Plock, Content Editor, 469.420.2609  
Contribute news

Disclaimer: The CoC Brief is a digest of the most important news selected for the American College of Surgeons Commission on Cancer from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The Commission on Cancer does not endorse any of the advertised products and services. Opinions expressed in the articles are those of the author and not of the American College of Surgeons and the Commission on Cancer.


Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

This edition of The CoC Brief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!

Recent issues

Aug. 21, 2013
Aug. 14, 2013
Aug. 7, 2013
July 31, 2013






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063